Company Mission At Akrimax Pharmaceuticals, we manufacture and market pharmaceutical products with unique and meaningful clinical advantages that improve the lives of patients. Our current commercial portfolio is focused in the areas of cardiovascular medicine, endocrinology and pain management. Akrimax is a sales and marketing company. Our mission is to acquire and commercialize under-promoted, under-utilized pharmaceutical products and those in late stage clinical development. Using a combination of revitalized promotion, product reformulation or the introduction of meaningful brand line extensions, we make new therapeutic options available to healthcare providers and patients.
View Top Employees from Akrimax Pharmaceuticals, LLCWebsite | http://www.akrimax.com/ |
Revenue | $18 million |
Employees | 33 (17 on RocketReach) |
Founded | 2008 |
Address | 11 Commerce Dr, Cranford, New Jersey 07016, US |
Phone | (908) 372-0506 |
Industry | Pharmaceuticals, Drug Manufacturing & Research, Product Development, Quality Assurance, Healthcare, Regulatory and Medical Affairs, Manufacturing, Sales and Marketing, Business Development, Finance, Managed Markets and Trade Relations |
Web Rank | 18 Million |
Competitors | Dexcel Pharma, Global Impact, Laboratoires Confab Laboratories, South Carolina Wildlife Federation, Upsher-Smith |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 325412 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular Akrimax Pharmaceuticals, LLC employee's phone or email?
The Akrimax Pharmaceuticals, LLC annual revenue was $18 million in 2023.
Donald Olsen is the President, Akrimax Pharmaceuticals, LLC of Akrimax Pharmaceuticals, LLC.
17 people are employed at Akrimax Pharmaceuticals, LLC.
Akrimax Pharmaceuticals, LLC is based in Cranford, New Jersey.
The NAICS codes for Akrimax Pharmaceuticals, LLC are [32541, 325412, 32, 325, 3254].
The SIC codes for Akrimax Pharmaceuticals, LLC are [283, 28].